title: Post-infarct biomaterials, left ventricular remodeling, and heart failure: is good good enough?
authors.affiliation: Department of Pharmacology and Toxicology,the Department of Surgery, The Center for Excellence in Cardiovascular-Renal Research, The University of Mississippi Medical Center, Jackson, MS 39216-4505, USA.
authors.forename: Fouad A
authors.initials: FA
authors.lastname: Zouein
authors.forename: Carlos
authors.initials: C
authors.lastname: Zgheib
authors.forename: Kenneth W
authors.initials: KW
authors.lastname: Liechty
authors.forename: George W
authors.initials: GW
authors.lastname: Booz
mesh_terms: D000959:Antihypertensive Agents / Q000627:therapeutic use; D001672:Biocompatible Materials; D018450:Disease Progression; D006333:Heart Failure / Q000209:etiology / Q000473:pathology*; D006801:Humans; D020100:Hydrogels / Q000627:therapeutic use; D009203:Myocardial Infarction / Q000150:complications / Q000188:drug therapy / Q000473:pathology*; D011379:Prognosis; D013997:Time Factors; D020257:Ventricular Remodeling
chemical_list: D000959:Antihypertensive Agents; D001672:Biocompatible Materials; D020100:Hydrogels